ITI Pharma and Healthcare Fund - Direct Plan - Growth Option
ITI Mutual Fund · Equity · mandate: ≥80% in the named sector/theme · benchmark: —
AUM (all plans)
234 cr
TER direct / regular
0.98% / 2.69%
CAGR (full)
15.6%
Sharpe (full)
0.62
Sharpe (bull ≤Sep-24)
2.95
Sharpe (sideways Oct-24→)
-0.00
Max drawdown
-16.1%
Months of data
57
Percentile ranks this fund within its peer pool; the leaderboard Score is
the weighted average of its fiscal-year percentiles (equity: active-return-rank blended
with IR-rank).
Equity curve
Drawdown
Fiscal-year record
FY
Return
vs category
Sharpe
months
FY22*
-2.9%
-3.4%
-0.68
4
FY23
-4.0%
-7.3%
-0.73
12
FY24
54.4%
8.1%
3.05
12
FY25
17.8%
10.8%
0.61
12
FY26
-4.1%
-2.9%
-0.73
12
FY27*
22.4%
4.1%
4.21
5
Active/Fund returns are TOTALS over the months covered — never annualized
(FY27* is year-to-date; a * row covers only part of the year).
%ile is the fund's percentile within its peer pool for that year.
Monthly returns (%)
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Year
2021
+4.2
+4.2
2022
-5.5
-5.4
+4.3
-0.1
-6.6
-2.3
+6.8
+0.0
+2.3
+3.8
+0.4
-3.6
-6.7
2023
-1.4
-4.4
+1.7
+4.4
+3.2
+7.2
+6.4
+0.6
+1.5
-3.6
+10.6
+4.8
+34.4
2024
+5.7
+3.6
+0.6
+0.9
-2.6
+6.9
+10.7
+6.0
+2.6
+0.5
+0.8
+2.1
+44.0
2025
-8.8
-7.9
+7.4
+1.6
+0.4
+3.4
+2.2
-4.4
-1.1
+3.4
-0.6
-2.9
-8.2
2026
-6.3
+5.5
-4.6
+8.3
+3.7
+5.3
+3.6
-0.1
+15.5
Quarterly average AUM & estimated net flows
Quarterly net flow estimate: AUM_q − AUM_(q−1)·(1+quarter return). AUM shown is the quarter AVERAGE (AMFI central disclosure). Positive = net inflows, ₹cr.
Source: AMFI's official all-scheme NAV history (portal report; official NAV history, net of TER by
construction). Monthly returns are month-end NAV chains; stale prints (>7 days before
month-end) drop out rather than carry. Benchmark series are the median of plain-vanilla
direct-plan index funds tracking each index (TRI minus ~10-25bp/yr tracking drag — verified
against true-TRI chains). Direct plans, growth option only. Sharpe uses rf 6%, arithmetic
monthly convention. Independence: all figures are computed from mandatory public disclosures with a
fixed methodology applied identically to every fund — no fund can pay for inclusion,
exclusion, placement, or altered presentation, and any material commercial relationship
will be disclosed on the affected pages.
Nothing here is investment advice; past performance does not
predict future returns. Generated 2026-08-25 05:37Z · data through Aug 2026 · leaderboard
· PMS leaderboard